原创力文档- 1
- 0
- 约6.44万字
- 约 8页
- 2017-06-14 发布于天津
- 举报
依鲁替尼治疗中血液毒性研究.pdf
Chronic Lymphocytic Leukemia ARTICLE
Incidence and risk factors of bleeding-related adverse events in
patients with chronic lymphocytic leukemia treated with ibrutinib
1,5, 1, 2 1 3 3
Andrew H. Lipsky, * Mohammed Z.H. Farooqui, * Xin Tian, Sabrina Martyr, Ann M. Cullinane, Khanh Nghiem,
1
文档评论（0）